Investigation of a fully mechanistic physiologically based pharmacokinetics model of absorption to support predictions of milk concentrations in breastfeeding women and the exposure of infants: A case study for albendazole
Susan Cole, Maria Malamatari, Andrew Butler, Mahnoor Arshad, Essam Kerwash · 2024
Read Investigation of a fully mechanistic physiologically based pharmacokinetics model of absorption to support predictions of milk concentrations in breastfeeding women and the exposure of infants: A case study for albendazole by Susan Cole, Maria Malamatari, Andrew Butler, Mahnoor Arshad, Essam Kerwash (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11578140.txt.
Description
Computer models estimate how much deworming drug reaches breast milk, Susan Cole and co-authors report in a 2024 study. Guidance now tells mothers to stop nursing on albendazole for lack of data. A body-simulation model predicts drug and active breakdown levels in blood and milk.
The model nails adult exposure and the food effect but misses some child data. Milk-to-blood ratios ran too high for the fatty parent drug, less so for its leaner metabolite. Worst-case math still puts infant doses low. More real milk samples are needed before guidance can safely soften, the authors caution.
Catalog record
| CREATOR | Susan Cole, Maria Malamatari, Andrew Butler, Mahnoor Arshad, Essam Kerwash |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |